Linda Anna, Zuiani Chiara, Londero Viviana, Bazzocchi Massimo
Department of Radiology, Azienda Ospedaliero-Universitaria, Via Colugna 50, 33100 Udine, Italy.
Breast. 2008 Feb;17(1):51-7. doi: 10.1016/j.breast.2007.06.004. Epub 2007 Aug 20.
The purpose of the study was to evaluate the outcome of initially only magnetic resonance mammography (MRM)-detected breast lesions as a function of radiologic features, history of breast cancer and lesion size. We evaluated core needle biopsy (CNB) (148) and follow-up (25) results of 173 initially only MRM-detected lesions-142 with and 31 without "second-look" correlate, as a function of (1) radiologic features (sonographic correlate, MRI BI-RADS category); (2) history of breast cancer; (3) MRM indication in case of history of breast neoplasm; (4) side and size of synchronous cancer; (5) lesion diameter. (1) Overall malignancy rate was 28.3% (49/173); significantly higher among lesions with a sonographic correlate (46/142), than among those without (3/31) (p=0.014). Frequencies of malignancy for MRI BI-RADS categories 2, 3, 4 and 5, were 0% (0/1), 5.4% (4/73), 26.1% (17/65) and 82.3% (28/34), respectively. (2) Malignancy rate was significantly higher in case of history of breast carcinoma (40/118 versus 9/55; p=0.027); in particular, of 42 MRI BI-RADS category 3 lesions in women with history of breast cancer and of 31 in patients without history, 3 (7%) and 1 (3%) proved to be malignant, respectively (non-significant). (3) Malignancy was more frequent when MRM was performed for pre-operative assessment than for follow-up (30/78 versus 10/40; non-significant). (4) Malignancy rate increased in presence of ipsilateral (19/35 versus 11/43; p=0.018), large (cut-off 6 mm: 30/75 versus 0/3, non-significant; 11 mm: 28/61 versus 2/17, p=0.011; 16 mm: 24/48 versus 6/30, p=0.015; 21 mm: 14/21 versus 16/57, p=0.004) primary tumors. (5) The frequency of malignancy was significantly higher in lesions equal to or larger than 6, 11 and 16 mm, compared with smaller lesions (6 mm: 45/136 versus 4/37, p=0.007; 11 mm: 21/51 versus 28/122, p=0.025; 16 mm: 12/24 versus 37/149, p=0.021). Radiologic features, history of breast cancer and large diameter are associated with high likelihood of malignancy in case of initially only MRM-detected lesions. Nevertheless, biopsy might be spared just for MRI BI-RADS 3 lesions in patients without history of breast carcinoma.
本研究的目的是评估最初仅通过磁共振乳腺成像(MRM)检测到的乳腺病变的结果,该结果是放射学特征、乳腺癌病史和病变大小的函数。我们评估了173例最初仅通过MRM检测到的病变的粗针活检(CNB)(148例)和随访(25例)结果,其中142例有“二次检查”相关性,31例无“二次检查”相关性,评估内容包括:(1)放射学特征(超声相关性、MRI BI-RADS分类);(2)乳腺癌病史;(3)有乳腺肿瘤病史时的MRM指征;(4)同步癌的部位和大小;(5)病变直径。(1)总体恶性率为28.3%(49/173);有超声相关性的病变(46/142)中的恶性率显著高于无超声相关性的病变(3/31)(p=0.014)。MRI BI-RADS分类为2、3、4和5的恶性频率分别为0%(0/1)、5.4%(4/73)、26.1%(17/65)和82.3%(28/34)。(2)有乳腺癌病史的患者恶性率显著更高(40/118对9/55;p=0.027);特别是,有乳腺癌病史的女性中42例MRI BI-RADS分类为3的病变和无乳腺癌病史的患者中31例此类病变,分别有3例(7%)和1例(3%)被证实为恶性(无统计学意义)。(3)为术前评估进行MRM时恶性情况比随访时更常见(30/78对10/40;无统计学意义)。(4)存在同侧(19/35对11/43;p=0.018)、大(截断值6mm:30/75对0/3,无统计学意义;11mm:28/61对2/17,p=0.011;16mm:24/48对6/30,p=0.015;21mm:14/21对16/57,p=0.004)原发性肿瘤时恶性率增加。(5)与较小病变相比,直径等于或大于6mm、11mm和16mm的病变中恶性频率显著更高(6mm:45/136对4/37,p=0.007;11mm:21/51对28/122,p=0.025;16mm:12/24对37/149,p=0.021)。放射学特征、乳腺癌病史和大直径与最初仅通过MRM检测到的病变中恶性可能性高相关。然而,对于无乳腺癌病史的患者,可能仅对MRI BI-RADS 3类病变可不进行活检。